⌘K
OverviewStock screenerAnalyst actionsCalendar
MarketsInvestorsSign in
StockUnited StatesNasdaqCM

TALK

Talkspace Inc

Healthcare · Health Information Services

5.25USD

+0.0000 (+0.00%)

DescriptionHistoricalFinancialsRelative ValueResearchNewsDiscussionOptionsPrice Chart ↗Fundamental Chart ↗

Estimates and surprises

Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.

PeriodConsensus EPS90 days agoRevisions up (30d)Revisions down (30d)
Current quarter$0.04▲$000
Next quarter$0.05▲$000
Current year$0.14▲$010
Next year$0.22▲$010

Recent quarters

Beat in 2 of the last 4

QuarterEstimateActualSurprise
2026-06-30$0.03$0.01-0.02 (-71.4%)
2026-03-31$0.02$0.02+0.00 (+0.7%)
2025-12-31$0.03$0.030.00 (0.0%)
2025-09-30$0.02$0.02+0.00 (+9.1%)

Wall Street coverage

36 ratings from 13 firms

Ratings are attributed to the research firm, not to individual analysts. See every ticker.

FirmActionRatingPrice TargetDate
BarclaysMaintainedEqual-Weight$5.5 $5.25Mar 10, 2026
KeybancDowngraded from OverweightSector Weight—Mar 10, 2026
Canaccord GenuityDowngraded from BuyHold—Mar 9, 2026
NeedhamDowngraded from BuyHold—Mar 9, 2026
TD CowenMaintainedBuy$6 $9Feb 20, 2026
NeedhamMaintainedBuy$5 $6Feb 19, 2026
KeybancMaintainedOverweight$4 $5Jan 8, 2026
BarclaysInitiatedEqual-Weight$3.5Dec 9, 2025
NeedhamReiteratedBuy$5Dec 2, 2025
Canaccord GenuityMaintainedBuy$5 $6Oct 31, 2025
NeedhamUpgraded from HoldBuy$5Oct 31, 2025
NeedhamReiteratedHold—May 6, 2025
Canaccord GenuityInitiatedBuy$5Apr 3, 2025
NeedhamReiteratedHold—Feb 21, 2025
KeybancInitiatedOverweight$4.5Dec 9, 2024
MizuhoInitiatedOutperform$5Dec 4, 2024
Northland Capital MarketsInitiatedOutperform$5Nov 20, 2024
NeedhamReiteratedHold—Oct 30, 2024
BarclaysMaintainedEqual-Weight$2 $3Oct 29, 2024
NeedhamReiteratedHold—Aug 6, 2024
NeedhamInitiatedHold—Jul 1, 2024
BarclaysMaintainedEqual-Weight$2.5 $3Feb 23, 2024
BarclaysInitiatedEqual-Weight$2.5Jan 3, 2024
TD CowenMaintainedOutperform$4 $5May 3, 2023
SVB LeerinkMaintainedMarket Perform$2 $1Nov 9, 2022

Insider transactions

73 filings from 13 insiders · 11 buy / 2 sell over 6m

Officers and directors of TALK, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.

InsiderActionSharesPriceValueDate
REILLY JOHN CHARLESOfficerSell40.3k$5.20$210kJun 18, 2026
REILLY JOHN CHARLESOfficerSell55.1k$5.21$287kJun 12, 2026
PAWAR MADHUDirectorGrant1.9k——Jun 1, 2026
SHACHAR EREZDirectorGrant2.4k——Jun 1, 2026
BRAUNSTEIN DOUGLAS LDirector and Beneficial Owner of more than 10% of a Class of SecurityGrant3.4k——Jun 1, 2026
WATSON KATELYNOfficerGrant38.8k——Mar 31, 2026
HARRIS IAN JIROChief Financial OfficerGrant145.4k——Mar 31, 2026
MARGOLIN GILChief Technology OfficerGrant58.2k——Mar 31, 2026
REILLY JOHN CHARLESOfficerGrant92.1k——Mar 31, 2026
COHEN JON RChief Executive OfficerGrant387.8k——Mar 31, 2026
PAWAR MADHUDirectorGrant2.1k——Feb 27, 2026
SHACHAR EREZDirectorGrant2.7k——Feb 27, 2026
BRAUNSTEIN DOUGLAS LDirector and Beneficial Owner of more than 10% of a Class of SecurityGrant3.8k——Feb 27, 2026
WATSON KATELYNOfficerGrant22.4k——Jan 30, 2026
HARRIS IAN JIROChief Financial OfficerGrant49.8k——Jan 30, 2026
MARGOLIN GILChief Technology OfficerGrant49.8k——Jan 30, 2026
REILLY JOHN CHARLESOfficerGrant20.5k——Jan 30, 2026
COHEN JON RChief Executive OfficerGrant74.7k——Jan 30, 2026
MARGOLIN GILChief Technology OfficerSell14.5k$3.26$47kDec 11, 2025
MARGOLIN GILChief Technology OfficerSell3.5k$3.15$11kDec 2, 2025

Analyst Notes

Sign in to write

No analyst notes on TALK yet.

Analyst Ratings

4 analysts covering

PeriodStrong BuyBuyHoldSellStrong SellConsensus
Current02400Hold2.67
1 mo ago02600Hold2.75
2 mo ago02600Hold2.75
Price target$6.38$5.25 – $9.00
+21.4% to target